Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech ...

Maravai LifeSciences (MRVI) announced its acquisition of intellectual property and relevant assets from Molecular Assemblies, or MAI. The ...

EST Maravai Lifesciences (MRVI) jumps 6% to $5.85 after MAI IP acquisition announcementInvest with Confidence: Follow TipRanks' Top Wall ...

Maravai Lifesciences Holdings Inc (MRVI) stock saw a decline, ending the day at $5.5 which represents a decrease of $-0.11 or -1.96% from the prior close of $5.61. The stock opened at $5.79 and ...

SAN DIEGO - Maravai LifeSciences, Inc. (NASDAQ: MRVI), a $796 million market cap company known for supplying life science reagents and services, has announced the acquisition of intellectual property ...

In this article, we are going to take a look at where Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) stands against other stocks under $5 with biggest upside potential. On January 20 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

1 Day MRVI 9.64% DJIA 1.24% S&P Mid Cap 400 1.64% Health Care/Life Sciences 0.00% ...

Revvity, Inc. RVTY is slated to report fourth-quarter 2024 results on Jan. 31, before market open. In the last reported ...

Grifols S.A. Cl B-2.25% €5.33B Grifols S.A.-1.16% €5.33B ...

Data is not available at this time. Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is ...